Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment

NCT01976052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2020-10-19

No results posted yet for this study

Summary

Potential biomarkers for obstructive sleep apnea (OSA), and full genomic screening will be evaluated and correlated to the degree of OSA and to effect of CPAP-treatment measured by polygraphy.

Conditions

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Malin Jonsson Fagerlund, MD, PhD · Karolinska University Hospital and Karolinska Institutet

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2017-06-01
Completion
2017-06-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976052 on ClinicalTrials.gov